
Sign up to save your podcasts
Or


Although most bypass grafts are sourced from other parts of a patient's body, bioengineers are examining new materials that might be used for bypass grafts to reduce the risk of second-site complications. Silk has been a standard material in sutures for decades, and is now showing promise as a biomaterial in bypass grafts. Might silkworms help repair clogged arteries? Dr. David Kaplan, endowed chair, the Stern Family Professor of Engineering, and professor & chair of the department of biomedical engineering at Tufts University, discusses the advantages of silk protein as a biomaterial and related applications to cardiology. When might this new technology be applied from the bench to the bedside? Dr. Janet Wright hosts.
Produced in Cooperation with
Tune in for a summary of some of the important information and research findings from the American College of Surgeons 96th Annual Clinical Congress, held October 3 - 7, 2010, in Washington, DC. This year’s meeting attracted more than 13,000 participants from around the world, who attended presentations on novel surgical techniques, the impact of surgeon availability on survival rates, application of surgical techniques to expanding patient populations, and risk factors associated with trauma incidents.
As the specialty of cosmetic medicine is rapidly evolving and expanding, so too are the roles of physician assistants and nurse practitioners in the field. Host Lisa Dandrea Lenell talks with some of the leading experts in plastic surgery and dermatology at the Aesthetic Extender Symposium, held October 8 - 10 in Miami Beach, Florida, which educates NPs and PAs about novel technologies and techniques in cosmetic medicine. Tune in to hear about the latest in botulinum toxins, fractionated lasers, hyaluronic fillers, the use of topical anesthetics, new methods of fat reduction and more.
Featured guests include:
On the 50th anniversary of the first successful prosthetic mitral valve replacement, how far has cardiac surgery come, and where are we headed? Tune in to hear Dr. Albert Starr, co-founder of the first artificial mitral valve, medical director of the Providence Heart and Vascular Institute, and director of Academic Affairs & Bioscience Development for Providence Health & Services in Portland, Oregon, recounts his first foray into the field of valvular disease and the extraordinary process of inventing the first artificial mitral valve. What complications did Dr. Starr encounter during the design process, and what breakthrough allowed for success in long-term artificial valve replacement? He also discusses the development of what was perhaps one of the first ventures into outcomes research, with the creation of a system for long-term follow up of patients receiving valve replacement. What does Dr. Starr see as the "next big thing" in cardiac surgery? Dr. Janet Wright hosts.
Produced in Cooperation withGastrointestinal surgery for the morbid obese has long been an option in treatment, providing positive long-lasting results such as normal blood glucose and glycosylated hemoglobin levels and the discontinuation of diabetes-related medications. Is type 2 diabetes an operable intestinal disease? Join host Dr. Steven Edelman and his guest, chief of gastrointestinal metabolic surgery at Weill Cornell Medical College, Dr. Francesco Rubino, as they discuss the implications of metabolic surgery for type 2 patients.
How are the latest advances in autogenous breast reconstruction changing the landscape of options available to women after mastectomy? Dr. Joseph Serletti, the Henry Royster - William Maul Measey professor of surgery and chief of the division of plastic surgery at Penn Medicine, discusses the history and evolution of breast reconstruction surgery, as well as the various types of free flap breast reconstruction that offer better cosmetic results for patients. How can the risk of thrombosis be minimized for patients undergoing these procedures? Dr. Lee Freedman hosts.
Produced in Cooperation withSinusitis can be debilitating. Complex frontal sinus disease may be categorized as infectious, or due to tumors or trauma. When frontal sinus disease is refractory to medical management, what types of surgery should we consider? Dr. James Palmer, associate professor and director of the division of rhinology in the department of otorhinolaryngology: head and neck surgery, at Penn Medicine, discusses advances in endoscopic surgical techniques for complex frontal sinus disease. Dr. Lee Freedman hosts.
When a woman is first diagnosed with breast cancer, a doctor's first concern is a treatment plan. But what happens after chemotherapy, radiation and surgery? Women must once again learn to reconnect with their bodies. Dr. Michael Krychman, executive director of the Southern California Center for Sexual Health and Survivorship Medicine, joins host Dr. Maureen Whelihan to discuss the treatment of low sexual desire in breast cancer survivors.
Trauma patients with injury to one or more limb often have additional systemic injuries that need to be considered during treatment. One approach to limb salvage is the ortho-plastic technique, which involves integrated soft tissue and bone. This conversation covers some of the latest advances in limb salvage techniques that might benefit trauma patients, as well as those with diabetes or peripheral vascular disease. Dr. Scott Levin, professor and chair of orthopaedic surgery and professor of plastic surgery at Penn Medicine, discusses strategies for avoiding amputation. Dr. Lee Freedman hosts.
Produced in Cooperation with
There are many potential options for treating left ventricular dysfunction, from medical to device therapies. Dr. Howard Eisen, Thomas J. Vischer Professor of Medicine and chief of the division of cardiology at Drexel University College of Medicine and Hahnemann University Hospital, in Philadelphia, Pennsylvania, outlines the roles of bypass surgery, percutaneous coronary intervention, cardiac resynchronization, surgical ventricular reconstruction and pharmacologic therapies for treating this condition. Specifically, he describes results of the recent Surgical Treatment for Ischemic Heart Failure, or STITCH, trial, and also tells us about the various ventricular-assist device options currently available. Dr. Alfred Bove hosts.